Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEVEN G COCA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1700972346
CMS profile
304074
Location
NEW YORK, NY

General Payments · PY2018–2024

$371,229.37

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$112,257.43

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $101,895.00 17
Travel and Lodging $9,909.84 8
Food and Beverage $452.59 10

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,683.35 5
PY2019 $3,086.24 5
PY2020 $9,825.00 7
PY2021 $7,927.50 6
PY2022 $133,741.91 36
PY2023 $101,707.94 23
PY2024 $112,257.43 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $8,019.70 04/28/2024 Travel and Lodging Undisputed 01/23/2026 1093897755 CMS
Alexion Pharmaceuticals, Inc. $1,077.22 04/28/2024 Travel and Lodging Undisputed 01/23/2026 1094051762 CMS
Alexion Pharmaceuticals, Inc. $82.20 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1093956684 CMS
Alexion Pharmaceuticals, Inc. $63.38 04/29/2024 Food and Beverage Undisputed 01/23/2026 1094002218 CMS
Alexion Pharmaceuticals, Inc. $33.53 04/30/2024 Food and Beverage Undisputed 01/23/2026 1093883961 CMS
Alexion Pharmaceuticals, Inc. $38.39 04/30/2024 Food and Beverage Undisputed 01/23/2026 1094034988 CMS
Alexion Pharmaceuticals, Inc. $33.49 05/01/2024 Food and Beverage Undisputed 01/23/2026 1093956011 CMS
Alexion Pharmaceuticals, Inc. $43.83 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1093963273 CMS
Alexion Pharmaceuticals, Inc. $12,395.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 1093956593 CMS
Alexion Pharmaceuticals, Inc. $111.91 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1093894986 CMS
Alexion Pharmaceuticals, Inc. $164.91 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1093908863 CMS
Alexion Pharmaceuticals, Inc. $20,100.00 06/11/2024 Consulting Fee Undisputed 01/23/2026 1093920292 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,820.00 01/25/2024 Consulting Fee Undisputed 01/23/2026 1086203771 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,040.00 09/19/2024 Consulting Fee Undisputed 01/23/2026 1086110890 CMS
Bayer Healthcare Pharmaceuticals Inc. $2,340.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1086179026 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.45 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118121417 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.45 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118121419 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $44.86 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118121423 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $44.86 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118121425 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $112.18 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118121427 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $270.07 02/12/2024 Travel and Lodging Undisputed 01/23/2026 1118121431 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 03/15/2024 Food and Beverage Undisputed 01/23/2026 1118121421 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 03/15/2024 Travel and Lodging Undisputed 01/23/2026 1118121429 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13,000.00 03/15/2024 Consulting Fee Undisputed 01/23/2026 1118121433 CMS
Renalytix AI, Inc. $5,000.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1116758702 CMS
Renalytix AI, Inc. $5,000.00 05/06/2024 Consulting Fee Undisputed 01/23/2026 1116758704 CMS
Renalytix AI, Inc. $5,000.00 06/03/2024 Consulting Fee Undisputed 01/23/2026 1116758706 CMS
Renalytix AI, Inc. $5,000.00 07/08/2024 Consulting Fee Undisputed 01/23/2026 1116758708 CMS
Renalytix AI, Inc. $5,000.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1116758710 CMS
Renalytix AI, Inc. $5,000.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 1116758712 CMS
Renalytix AI, Inc. $5,000.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 1116758714 CMS
Renalytix AI, Inc. $5,000.00 11/01/2024 Consulting Fee Undisputed 01/23/2026 1116758716 CMS
Renalytix AI, Inc. $5,000.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1116758718 CMS
Renalytix AI, Inc. $5,000.00 12/31/2024 Consulting Fee Undisputed 01/23/2026 1116758720 CMS
SCPHARMACEUTICALS INC. $1,200.00 10/16/2024 Consulting Fee Undisputed 01/23/2026 1132304102 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.